14) Cutaneous/Ocular Therapeutics
Abstract
Focuses on therapeutic strategies to effectively minimize injuries to dermal (i.e., skin) and ocular tissues resulting from exposure to chemical warfare agents (CWAs). Involves the development of effective practical field and clinic management strategies and physical and pharmacological interventions to treat the injury processes. This work is designed to develop potential candidates that will ultimately be submitted for FDA licensure or new indications for previously licensed products for use in the treatment of chemical warfare casualties.
Document Details
- Document Type
- Accomplishment
- Publication Date
- Oct 01, 2015
- Source ID
- 6d3b7e04d3ddef57fefe259e7e1db8a5